期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
欧前胡素抑制compound48/80介导的肥大细胞脱颗粒作用机制研究 被引量:2
1
作者 黄宪 王重阳 +3 位作者 朱莲花 姜京植 金珊 延光海 《延边大学医学学报》 CAS 2019年第1期1-4,共4页
[目的]探讨欧前胡素抑制compound48/80介导的肥大细胞脱颗粒作用机制.[方法]取雄性SD大鼠的腹腔肥大细胞进行体外培养,利用compound48/80诱导肥大细胞活化,治疗组分别加入10,20,40μmol/L的欧前胡素.利用ELISA法检测各组肿瘤坏死因子-α... [目的]探讨欧前胡素抑制compound48/80介导的肥大细胞脱颗粒作用机制.[方法]取雄性SD大鼠的腹腔肥大细胞进行体外培养,利用compound48/80诱导肥大细胞活化,治疗组分别加入10,20,40μmol/L的欧前胡素.利用ELISA法检测各组肿瘤坏死因子-α(TNF-α)及白细胞介素-6(IL-6)水平,利用Western blot法检测NF-κB p65水平.[结果]与正常对照组比较,compound48/80可激活实验大鼠腹腔肥大细胞,增加细胞核内NF-κB p65表达量,减少胞浆中NF-κB p65表达量,促进NF-κB p65核转位;与正常对照组比较,模型对照组TNF-α,IL-6水平均明显升高(P<0.05).与模型对照组比较,欧前胡素各剂量组细胞核内NF-κB p65表达量明显减少,胞浆中NF-κB p65表达量明显增加,欧前胡素抑制NF-κB p65核转位,并明显降低肥大细胞TNF-α,IL-6水平(P<0.05),且作用效果呈浓度依赖性增强.[结论]欧前胡素可通过调节NF-κB激活抑制肥大细胞脱颗粒,从而抑制炎性细胞因子的释放. 展开更多
关键词 compound48/80 欧前胡素 肥大细胞 大鼠
下载PDF
熟地黄抗Compound48/80诱导过敏反应的活性部位研究
2
作者 孔晓妮 温学森 《中国中药杂志》 CAS CSCD 北大核心 2009年第5期632-634,共3页
关键词 熟地黄 水煎液 剂量 抑制率 补阴药 汤剂 用药量 compound48/80 过敏反应 活性部位
原文传递
基于实时细胞分析的化合物48/80诱导肥大细胞脱颗粒评价研究 被引量:3
3
作者 王曼 庄朋伟 +3 位作者 周会芳 王诗羽 崔广智 张艳军 《中国药理学通报》 CAS CSCD 北大核心 2014年第3期145-146,共2页
药物引起的过敏/类过敏反应是临床常见的不良反应之一.传统的过敏/类过敏反应评价方法多选用豚鼠,通过考察给药后豚鼠出现的喷嚏、抓鼻、呼吸困难、抽搐昏倒或死亡等现象,以判断药物是否可以引起过敏/类过敏反应[1],存在实验周期性长、... 药物引起的过敏/类过敏反应是临床常见的不良反应之一.传统的过敏/类过敏反应评价方法多选用豚鼠,通过考察给药后豚鼠出现的喷嚏、抓鼻、呼吸困难、抽搐昏倒或死亡等现象,以判断药物是否可以引起过敏/类过敏反应[1],存在实验周期性长、灵敏度低、误差大等缺点. 展开更多
关键词 RBL-2H3 脱颗粒 实时细胞分析系统 compound48 80 过敏 类过敏
下载PDF
抗炎新药Acetamide45对化合物48/80诱发的皮肤瘙痒的作用机制研究 被引量:1
4
作者 黄育文 吴登唱 +1 位作者 徐翔 陈忠 《中国药房》 CAS CSCD 北大核心 2006年第14期1057-1058,共2页
目的探讨抗炎新药Acetamide45对化合物48/80诱发的皮肤瘙痒的作用机制。方法将ICR小鼠随机分成生理盐水组、模型组(生理盐水+化合物48/80)、美吡拉明阳性对照组及Acetamide450.1、0.3、1、3mg/kg剂量组,背部皮下注射化合物48/80或组胺... 目的探讨抗炎新药Acetamide45对化合物48/80诱发的皮肤瘙痒的作用机制。方法将ICR小鼠随机分成生理盐水组、模型组(生理盐水+化合物48/80)、美吡拉明阳性对照组及Acetamide450.1、0.3、1、3mg/kg剂量组,背部皮下注射化合物48/80或组胺诱发小鼠的瘙痒行为,观察给药前、后小鼠的瘙痒次数。结果与组胺H1受体拮抗药美吡拉明相仿,腹腔内注射Acetamide45不仅可剂量依赖性地抑制由化合物48/80诱发的小鼠瘙痒行为(P<0.05),而且对组胺诱发的瘙痒行为有效(P<0.05)。结论Acetamide45作为一种新型抗炎药,能明显改善化合物48/80诱发的瘙痒行为,其作用可能通过其抑制组胺的释放及阻滞H1受体相关。本研究为Acetamide45早日应用于临床提供了初步证据。 展开更多
关键词 ACETAMIDE 45 化合物48/80 组胺 皮肤瘙痒 作用机制
下载PDF
Sex Differences in Scratching Behaviors Induced by Intradermal Injections of Pruritogenic Chemicals in C57BL/6 Mice
5
作者 Chunwei Liu Liang Liang +6 位作者 Yong Han Ming Zhang Yabin Xie Wenjuan Han Sanjue Hu Hua Zhang Hui Xu 《Neuroscience & Medicine》 2012年第3期314-320,共7页
Pruritus is an individual unpleasant sensation of human sensory nervous system. In the physiological condition it excerts a self-protective mechanism to protect the skin against external harmful agents. Pruritoceptive... Pruritus is an individual unpleasant sensation of human sensory nervous system. In the physiological condition it excerts a self-protective mechanism to protect the skin against external harmful agents. Pruritoceptive itch is also a major symptom of skin disease and a common reason for consulting a dermatologist in clinic. It has been well known that both histamine-dependent and histamine-independent pathways mediate acute and chronic itch sensations. Previous studies have showed common neural pathways partially shared by itch and pain sensation, and significant sex differences in pain sensation. However, sex difference in itch sensation has not been given too much attention as the majority of itch studies were done in male mice or rats till now. In the present study, we compared the scratching behaviors induced by pruritogenic agents in male and female C57BL/6 mice. The results showed that both males and females exhibited scratching behaviors in response to the intradermal injection of histamine-dependent and histamine-independent pruritogenic chemicals. Moreover, the number of scratching behaviors in response to compound 4880 and chloroquine were significantly higher in females. These results suggested that sex differences occured in histamine-dependent compound 4880-induced and histamine-independent chloroquine-induced itch sensations, but not in histamine-independent SLIGRL-NH2-induced itch sensation. 展开更多
关键词 SCRATCHING PRURITUS SEX Difference compound48/80 CHLOROQUINE SLIGRL-NH2
下载PDF
RBL-2H3细胞不适合用于类过敏模型的建立
6
作者 张小雨 齐睿娟 +5 位作者 李西蒙 韩宜芯 费巧玲 蔡润兰 齐云 高源 《中国药理学通报》 CAS CSCD 北大核心 2020年第3期438-443,共6页
目的考察RBL-2H3细胞是否适用于建立类过敏反应模型。方法用荧光定量聚合酶链反应考察RBL-2H3细胞上Mas相关G蛋白偶联受体(Mas-related G protein cou-pled receptor,Mrgpr)B2的表达情况;用显微镜观察和MTS法考察Compound 48/80对RBL-2H... 目的考察RBL-2H3细胞是否适用于建立类过敏反应模型。方法用荧光定量聚合酶链反应考察RBL-2H3细胞上Mas相关G蛋白偶联受体(Mas-related G protein cou-pled receptor,Mrgpr)B2的表达情况;用显微镜观察和MTS法考察Compound 48/80对RBL-2H3细胞活力的影响;测定不同浓度Compound 48/80刺激RBL-2H3细胞脱颗粒释放的β-己糖胺酶含量,对比RBL-2H3细胞、人肥大细胞系LAD2和大鼠腹腔肥大细胞(rat peritoneal mast cells,RPMCs)对Compound 48/80响应性的差异。结果RBL-2H3细胞可表达MrgprB2受体。Compound 48/80能剂量依赖性地诱导RBL-2H3细胞释放β-己糖胺酶,但在高剂量(≥20 mg·L^-1)时对RBL-2H3的细胞活力产生明显影响,此时释放的β-己糖胺酶应当是由于其细胞毒作用引起细胞破裂所致。同在无毒剂量(10 mg·L^-1)的Compound 48/80刺激下,LAD2和RPMCs的响应性良好,β-己糖胺酶释放量分别为空白对照的15.02倍和16.05倍,而RBL-2H3细胞仅为空白对照的2.35倍。结论RBL-2H3细胞对Compound 48/80的响应性差,表明其并不适用于建立类过敏反应模型。 展开更多
关键词 RBL-2H3 类过敏反应 脱颗粒 Compound 48/80 β-己糖胺酶 MrgprX2
下载PDF
Compound 48/80诱导BN大鼠类过敏反应的蛋白组学研究 被引量:1
7
作者 陈桂荣 徐煜彬 +2 位作者 冉小库 韩雪莹 窦德强 《现代药物与临床》 CAS 2019年第5期1279-1284,共6页
目的探讨Compound 48/80诱导BN大鼠类过敏反应的发生机制,采用iTRAQ蛋白组学技术对类过敏的发生过程进行研究,并鉴定候选标志物。方法将BN大鼠按体质量随机分为对照1组、2组和Compound 48/80 1组、2组,每组各6只。对照组iv生理盐水5 mL/... 目的探讨Compound 48/80诱导BN大鼠类过敏反应的发生机制,采用iTRAQ蛋白组学技术对类过敏的发生过程进行研究,并鉴定候选标志物。方法将BN大鼠按体质量随机分为对照1组、2组和Compound 48/80 1组、2组,每组各6只。对照组iv生理盐水5 mL/kg,Compound 48/80组分别iv Compound 48/80 2.5 mL/kg,取血浆样品经蛋白提取、电泳和质谱分析,确定类过敏反应差异蛋白。结果通过蛋白组学研究共鉴定10585个肽段,总共鉴定1987个蛋白质。提取7个与类过敏反应相关的差异蛋白。与对照组比较,Ica、Galectin-1上调;Hpse HEP、Mpo、MMP8、Hprt1、MMP9下调。结论Hpse HEP、Mpo、MMP8、Hprt1、Ica、MMP9、Galectin-1均可以作为类过敏反应的候选生物标志物。 展开更多
关键词 compound48/80 类过敏反应 蛋白组学 差异蛋白
原文传递
Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement 被引量:8
8
作者 TANG Ya-ling YANG Yong-zong +4 位作者 WANG Shuang HUANG Tao TANG Chao-ke XU Zeng-xiang SUN Yu-hui 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第3期319-325,共7页
Background Study of the relationship between mast cells and atherosclerosis is mostly dependent on pathological observation and cytology experiments. To investigate the effects of mast cells degranulation on plaque an... Background Study of the relationship between mast cells and atherosclerosis is mostly dependent on pathological observation and cytology experiments. To investigate the effects of mast cells degranulation on plaque and their possible mechanisms we used apolipoprotein E knockout mice which had been placed perivascular common carotid collar with mast cells degranulator compound 48-80. Methods Forty apolipoprotein E knockout mice were fed a western-type diet and operated on with placement of perivascular right common carotid collar. Four weeks after surgery, the mice were intraperitoneally injected with compound 48-80 (0.5 mg/kg) or D-Hanks every other day for 4 times. The serum lipids and activity of tryptase were measured. Tissue sections were stained with hematoxylin and eosin. Corresponding sections were stained with toluidine blue and immunohistochemically with antibodies against macrophage-specific antigen, a-smooth muscle actin, interleukin-1β and von Willebrand factor. Simultaneously, basic fibroblast growth factor was detected by in situ hybridization and immunofluorescence. Results No pathological change was observed in common carotid non-collar placement but atherogenesis in common carotid collar placement of both groups. There was a significant increase in plaque area ((5.85±0.75)×10^4 vs (0.86±0.28)×10^4 um^2, P 〈0.05), the degree of lumen stenosis ((81±15)% vs (41±12)%, P 〈0.05), the activity of tryptase in serum ((0.57±0.13) U/L vs (0.36±0.10) U/L, P 〈0.05), and the percentage of degranulated mast cells ((80.6±17.8)% vs (13.5±4.1)%, P 〈0.05). The expressions of macrophage-specific antigen, α-smooth muscle actin, interleukin-1β, basic fibroblast growth factor and the density of neovessel in plaque were more in the compound 48-80 group than in the control group. Conclusions Perivascular common carotid collar placement can promote atherosclerotic plaque formation in apolipoprotein E knockout mice. Compound 48-80 increases plaque area and the degree of lumen stenosis by the mechanism that compound 48-80 promotes proliferation of smooth muscle cells and aggregation of macrophages. Compound 48-80 promotes angiogenesis in plaque. The mechanism is potentially that compound 48-80 increases the expressions of basic fibroblast growth factor mRNA and protein in plaque. Compound 48-80 enhances the expression of interleukin-1β in plaque. 展开更多
关键词 mast cells compound 48-80 atherosclerosis PLAQUE
原文传递
Influence of cromolyn sodium and compound 48/80 administered prior to and after reperfusion on the third day's survival rate in a rat intestinal ischemia model 被引量:2
9
作者 HEI Zi-qing HUANG Pin-jie GAN Xiao-liang PANG Hong-yu WEI Jing 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第18期1843-1847,共5页
Intestinal ischemia occurs in a wide variety of clinical manifestations. The gut barrier is broken down by bacterial translocation after small intestinal ischemia reperfusion injury (IIRI), which can result in many ... Intestinal ischemia occurs in a wide variety of clinical manifestations. The gut barrier is broken down by bacterial translocation after small intestinal ischemia reperfusion injury (IIRI), which can result in many clinical consequences, even death. The intestinal mucosal mast cells (IMMCs) serve as a unique cellular source of large amounts of vasoactive mediators, and they can influence local tissue reactions. We and others have previously shown that IIRI could activate IMMCs, make them degranulate and release a mass of inflammatory mediators, which in turn aggravate IIRI. 展开更多
关键词 intestinal ischemia reperfusion cromolyn sodium compound 48/80 mast cells survival rate
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部